Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
It has been demonstrated that in patients with epithelial ovarian cancer and malignant germ cell tumors of the ovary, macrophage colony-stimulating factor (M-CSF) is significantly elevated in the serum compared to healthy individuals. Therefore, M-CSF has been suggested as a tumor marker in these malignancies. In the present study, the tumor marker potential of the serum M-CSF concentration in patients with squamous cell carcinomas of the head and neck (SCCHN) was investigated. The serum M-CSF concentration was determined by a quantitative sandwich enzyme immunoassay in 59 patients suffering from SCCHN and 59 healthy controls. A significant difference in the mean serum concentration of M-CSF between the patients with SCCHN and the control group was found (p = 0.002). The M-CSF serum concentration correlated neither with the stage of disease nor with histopathological grading, and no correlation with serum C-reactive protein was found. The serum M-CSF concentration could be of interest as a tumor marker in SCCHN.
Department of Otolaryngology, Head and Neck Surgery, University of Marburg, Marburg, Germany. kuropkat@med.uni-marburg.de
C
C
Kuropkat
A A
AA
Dünne
S
S
Plehn
M
M
Ossendorf
U
U
Herz
H
H
Renz
J A
JA
Werner
D014408:Biomarkers, Tumor / Q000097:blood; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000473:pathology* / Q000601:surgery; D006258:Head and Neck Neoplasms / Q000097:blood / Q000473:pathology* / Q000601:surgery; D006801:Humans; D016173:Macrophage Colony-Stimulating Factor / Q000097:blood*; D009367:Neoplasm Staging; D012016:Reference Values
D014408:Biomarkers, Tumor; D016173:Macrophage Colony-Stimulating Factor